 Nathan Artz
Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 19 | 2022 | 114 | 3.540 |
Why?
| | Image Interpretation, Computer-Assisted | 6 | 2016 | 20 | 1.460 |
Why?
| | Image Enhancement | 5 | 2016 | 13 | 1.330 |
Why?
| | Renal Circulation | 5 | 2016 | 6 | 1.140 |
Why?
| | Metals | 5 | 2017 | 5 | 1.120 |
Why?
| | Kidney Transplantation | 5 | 2016 | 114 | 1.060 |
Why?
| | Magnetic Resonance Angiography | 4 | 2022 | 9 | 0.940 |
Why?
| | Artifacts | 4 | 2017 | 7 | 0.880 |
Why?
| | Kidney | 3 | 2011 | 89 | 0.860 |
Why?
| | Reproducibility of Results | 12 | 2017 | 197 | 0.860 |
Why?
| | Imaging, Three-Dimensional | 4 | 2017 | 11 | 0.800 |
Why?
| | Spin Labels | 6 | 2016 | 6 | 0.780 |
Why?
| | Prostheses and Implants | 3 | 2017 | 8 | 0.750 |
Why?
| | Liver | 3 | 2020 | 119 | 0.710 |
Why?
| | Phantoms, Imaging | 7 | 2019 | 10 | 0.660 |
Why?
| | Algorithms | 4 | 2016 | 103 | 0.650 |
Why?
| | Adipose Tissue | 2 | 2015 | 27 | 0.630 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 116 | 0.630 |
Why?
| | Renal Artery | 2 | 2016 | 5 | 0.530 |
Why?
| | Meglumine | 1 | 2014 | 1 | 0.490 |
Why?
| | Organometallic Compounds | 1 | 2014 | 1 | 0.490 |
Why?
| | Data Compression | 1 | 2014 | 1 | 0.490 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2020 | 20 | 0.480 |
Why?
| | Obesity | 1 | 2015 | 124 | 0.480 |
Why?
| | Fatty Liver | 1 | 2012 | 4 | 0.450 |
Why?
| | Middle Aged | 8 | 2020 | 648 | 0.440 |
Why?
| | Kidney Function Tests | 2 | 2016 | 20 | 0.420 |
Why?
| | Sensitivity and Specificity | 7 | 2016 | 145 | 0.410 |
Why?
| | Microspheres | 1 | 2011 | 1 | 0.400 |
Why?
| | Contrast Media | 3 | 2022 | 24 | 0.390 |
Why?
| | Adult | 8 | 2020 | 1233 | 0.380 |
Why?
| | Female | 11 | 2020 | 3436 | 0.370 |
Why?
| | Humans | 18 | 2022 | 6599 | 0.360 |
Why?
| | Bariatric Surgery | 2 | 2020 | 9 | 0.360 |
Why?
| | Signal Processing, Computer-Assisted | 3 | 2016 | 3 | 0.320 |
Why?
| | Aged | 6 | 2020 | 375 | 0.310 |
Why?
| | Male | 9 | 2020 | 3197 | 0.310 |
Why?
| | Hip Joint | 2 | 2017 | 4 | 0.280 |
Why?
| | Knee Joint | 2 | 2017 | 3 | 0.280 |
Why?
| | Models, Statistical | 2 | 2019 | 34 | 0.270 |
Why?
| | Echo-Planar Imaging | 2 | 2015 | 2 | 0.250 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2019 | 11 | 0.240 |
Why?
| | Animals | 4 | 2013 | 563 | 0.230 |
Why?
| | Kidney Medulla | 2 | 2012 | 3 | 0.210 |
Why?
| | Kidney Failure, Chronic | 2 | 2016 | 163 | 0.210 |
Why?
| | Gadolinium | 1 | 2021 | 3 | 0.200 |
Why?
| | Perfusion | 2 | 2011 | 8 | 0.200 |
Why?
| | Obesity, Morbid | 1 | 2020 | 9 | 0.190 |
Why?
| | Radio Waves | 2 | 2017 | 3 | 0.180 |
Why?
| | Protons | 2 | 2020 | 6 | 0.180 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2019 | 2 | 0.180 |
Why?
| | Monte Carlo Method | 1 | 2019 | 5 | 0.170 |
Why?
| | Melanoma | 1 | 2018 | 4 | 0.170 |
Why?
| | Skin Neoplasms | 1 | 2018 | 8 | 0.170 |
Why?
| | Oxygen | 3 | 2016 | 13 | 0.160 |
Why?
| | Body Mass Index | 2 | 2018 | 155 | 0.160 |
Why?
| | Arthroplasty, Replacement | 1 | 2017 | 2 | 0.160 |
Why?
| | Postoperative Complications | 1 | 2018 | 177 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2015 | 10 | 0.130 |
Why?
| | Joint Prosthesis | 1 | 2014 | 1 | 0.130 |
Why?
| | Perfusion Imaging | 2 | 2012 | 2 | 0.130 |
Why?
| | Joints | 1 | 2014 | 3 | 0.130 |
Why?
| | Regression Analysis | 1 | 2015 | 56 | 0.130 |
Why?
| | Swine | 2 | 2011 | 5 | 0.130 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 99 | 0.120 |
Why?
| | Ankle | 1 | 2014 | 1 | 0.120 |
Why?
| | Body Water | 1 | 2014 | 4 | 0.120 |
Why?
| | Brachial Plexus | 1 | 2014 | 3 | 0.120 |
Why?
| | Knee Prosthesis | 1 | 2014 | 1 | 0.120 |
Why?
| | Nephrology | 1 | 2013 | 18 | 0.120 |
Why?
| | Kidney Diseases | 1 | 2013 | 69 | 0.110 |
Why?
| | HSP27 Heat-Shock Proteins | 1 | 2012 | 1 | 0.110 |
Why?
| | Triglycerides | 1 | 2012 | 20 | 0.110 |
Why?
| | Reference Values | 1 | 2012 | 40 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2012 | 55 | 0.110 |
Why?
| | Phlebography | 2 | 2022 | 6 | 0.110 |
Why?
| | Mice | 1 | 2012 | 290 | 0.100 |
Why?
| | Regional Blood Flow | 1 | 2011 | 3 | 0.100 |
Why?
| | Kidney Cortex | 1 | 2011 | 2 | 0.100 |
Why?
| | Sus scrofa | 1 | 2011 | 1 | 0.100 |
Why?
| | Arteries | 1 | 2011 | 3 | 0.100 |
Why?
| | Statistics as Topic | 1 | 2011 | 18 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2011 | 202 | 0.100 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2012 | 184 | 0.090 |
Why?
| | Longitudinal Studies | 2 | 2020 | 123 | 0.080 |
Why?
| | Child | 3 | 2022 | 3146 | 0.080 |
Why?
| | Prospective Studies | 2 | 2020 | 508 | 0.080 |
Why?
| | Blood Flow Velocity | 2 | 2016 | 6 | 0.060 |
Why?
| | Glomerular Filtration Rate | 2 | 2012 | 111 | 0.050 |
Why?
| | Biopsy | 1 | 2020 | 56 | 0.050 |
Why?
| | Radiation Dosage | 1 | 2019 | 5 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 3 | 0.040 |
Why?
| | Calibration | 1 | 2016 | 5 | 0.040 |
Why?
| | Transplant Recipients | 1 | 2016 | 8 | 0.040 |
Why?
| | Tissue Donors | 1 | 2016 | 28 | 0.030 |
Why?
| | Young Adult | 1 | 2018 | 652 | 0.030 |
Why?
| | Computer Simulation | 1 | 2014 | 22 | 0.030 |
Why?
| | Models, Biological | 1 | 2014 | 46 | 0.030 |
Why?
| | Pattern Recognition, Automated | 1 | 2014 | 1 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2018 | 1251 | 0.030 |
Why?
| | Child, Preschool | 1 | 2018 | 1459 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 1 | 0.030 |
Why?
| | Arterial Pressure | 1 | 2012 | 1 | 0.030 |
Why?
| | Diuretics | 1 | 2012 | 4 | 0.030 |
Why?
| | F2-Isoprostanes | 1 | 2012 | 3 | 0.030 |
Why?
| | Hematocrit | 1 | 2012 | 5 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 2012 | 6 | 0.030 |
Why?
| | Heat-Shock Proteins | 1 | 2012 | 6 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2012 | 6 | 0.030 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 14 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 34 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2012 | 13 | 0.030 |
Why?
| | Linear Models | 1 | 2012 | 55 | 0.030 |
Why?
| | Creatinine | 1 | 2012 | 52 | 0.030 |
Why?
| | Disease Progression | 1 | 2012 | 104 | 0.030 |
Why?
| | Biomarkers | 1 | 2012 | 120 | 0.030 |
Why?
| | Adolescent | 1 | 2018 | 2087 | 0.030 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|